Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: A randomized controlled trial

Clinical Infectious Diseases

Volumn 60, Issue 3, 2015, Pages 405-414

  Aguado, José María ^a   Vazquez, Lourdes ^b   Fernandez Ruiz, Mario ^a   Villaescusa, Teresa ^c   Ruiz Camps, Isabel ^d   Barba, Pere ^d   Silva, Jose T ^a   Batlle, Montserrat ^e   Solano, Carlos ^f   Gallardo, David ^g   Heras, Inmaculada ^h   Polo, Marta ⁱ   Varela, Rosario ^j   Vallejo, Carlos ^k   Olave, Teresa ^l   López Jiménez, Javier ^m   Rovira, Montserrat ⁿ   Parody, Rocío ^o   Cuenca Estrella, Manuel ^p  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^c Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^f Instituto Universitario IVI INCLIVA   (Spain)

^g HOSPITAL JOSEP TRUETA   (Spain)

^h HOSPITAL MORALES MESEGUER   (Spain)

ⁱ HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^j HOSPITAL JUAN CANALEJO   (Spain)

^k HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^l HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^m HOSPITAL RAMÓN Y CAJAL   (Spain)

ⁿ HOSPITAL CLÍNIC   (Spain)

^o HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^p INSTITUTO DE SALUD CARLOS III   (Spain)

more..

Author keywords

clinical trial; galactomannan; invasive aspergillosis; monitoring; PCR

Indexed keywords

ANTIBIOTIC AGENT; ANTILEUKEMIC AGENT; FLUCONAZOLE; FUNGAL DNA; GALACTOMANNAN; MANNAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; ASPERGILLUS; CANCER CHEMOTHERAPY; CANCER PATIENT; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; DISEASE FREE SURVIVAL; EARLY DIAGNOSIS; FEBRILE NEUTROPENIA; FEMALE; FUNGAL DETECTION; GALACTOMANNAN ASSAY; GRAFT RECIPIENT; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HIGH RISK PATIENT; HUMAN; INCIDENCE; INDUCTION CHEMOTHERAPY; INFECTION PREVENTION; INTERMETHOD COMPARISON; INVASIVE ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; MORTALITY; MULTICENTER STUDY; MYELODYSPLASTIC SYNDROME; OPEN STUDY; PARALLEL DESIGN; POLYMERASE CHAIN REACTION SYSTEM; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; RISK REDUCTION; TREATMENT DURATION; ACUTE MYELOBLASTIC LEUKEMIA; AGED; ASPERGILLOSIS; BLOOD; CLINICAL TRIAL; COMPLICATION; GENETICS; MIDDLE AGED; SECONDARY PREVENTION;

ADULT; AGED; ASPERGILLOSIS; ASPERGILLUS; DNA, FUNGAL; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MANNANS; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; REAL-TIME POLYMERASE CHAIN REACTION; SECONDARY PREVENTION;

EID: 84922423547     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu833     Document Type: Article

References (35)

1. Pagano L, Caira M, Nosari A, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study-Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007; 45: 1161-70
2. Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50: 1091-100
3. Montagna MT, Lovero G, Coretti C, et al. SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients. Infection 2014; 42: 141-51
4. Nucci M, Garnica M, Gloria AB, et al. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil. Clin Microbiol Infect 2013; 19: 745-51
5. Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91: 1068-75
6. Maertens JA, Nucci M, Donnelly JP. The role of antifungal treatment in hematology. Haematologica 2012; 97: 325-7
7. Maertens J, Theunissen K, Verhoef G, et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005; 41: 1242-50.
8. Cuenca-Estrella M, Bassetti M, Lass-Florl C, Racil Z, Richardson M, Rogers TR. Detection and investigation of invasive mould disease. J Antimicrob Chemother 2011; 66(suppl 1): i15-24
9. Aceti A, Corvaglia L, Faldella G. Infant formulas thickened with carob bean gum causing false-positive galactomannan test reactivity. Pediatr Infect Dis J 2008; 27: 769
10. Scotter JM, Campbell P, Anderson TP, Murdoch DR, Chambers ST, Patton WN. Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis. Pathology 2005; 37: 246-53
11. Florent M, Katsahian S, Vekhoff A, et al. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies. J Infect Dis 2006; 193: 741-7
12. Halliday C, Hoile R, Sorrell T, et al. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia. Br J Haematol 2006; 132: 478-86
13. Suarez F, Lortholary O, Buland S, et al. Detection of circulating Aspergillus fumigatus DNA by real-Time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance. J Clin Microbiol 2008; 46: 3772-7
14. Morrissey CO, Chen SC, Sorrell TC, et al. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infect Dis 2013; 13: 519-28
15. Nabili M, Shokohi T, Janbabaie G, Hashemi-Soteh MB, Ali-Moghaddam K, Aghili SR. Detection of invasive aspergillosis in bone marrow transplant recipients using real-Time PCR. J Glob Infect Dis 2013; 5: 68-75
16. Springer J, Morton CO, Perry M, et al. Multicenter comparison of serum and whole-blood specimens for detection of Aspergillus DNA in high-risk hematological patients. J Clin Microbiol 2013; 51: 1445-50
17. Kourkoumpetis TK, Fuchs BB, Coleman JJ, Desalermos A, Mylonakis E. Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections. Clin Infect Dis 2012; 54: 1322-31
18. Marchetti O, Lamoth F, Mikulska M, et al. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant 2012; 47: 846-54
19. Meije Y, Aguado JM, Cuenca-Estrella M. Silent and prolonged Aspergillus DNAemia in oncohematological patients receiving antifungal prophylaxis: a new phenomenon with clinical implications. Bone Marrow Transplant 2011; 46: 1016-7
20. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-21
21. Cuenca-Estrella M, Meije Y, Díaz-Pedroche C, et al. Value of serial quantification of fungal DNA by a real-Time PCR-based technique for early diagnosis of invasive aspergillosis in patients with febrile neutropenia. J Clin Microbiol 2009; 47: 379-84
22. White PL, Perry MD, Loeffler J, et al. Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens. J Clin Microbiol 2010; 48: 3753-5
23. Bernal-Martínez L, Gago S, Buitrago MJ, Gómez-López A, Rodríguez-Tudela JL, Cuenca-Estrella M. Analysis of performance of a PCR-based assay to detect DNA of Aspergillus fumigatus in whole blood and serum: a comparative study with clinical samples. J Clin Microbiol 2011; 49: 3596-9
24. White PL, Mengoli C, Bretagne S, et al. Evaluation of Aspergillus PCR protocols for testing serum specimens. J Clin Microbiol 2011; 49: 3842-8
25. Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-Analysis. Lancet Infect Dis 2009; 9: 89-96
26. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011; 52: e56-93
27. Wingard JR, Ribaud P, Schlamm HT, Herbrecht R. Changes in causes of death over time after treatment for invasive aspergillosis. Cancer 2008; 112: 2309-12
28. Asano-Mori Y, Kanda Y, Oshima K, et al. False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation. J Antimicrob Chemother 2008; 61: 411-6
29. Cornely OA, Maertens J, Winston DJ, et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007; 356: 348-59
30. Ullmann AJ, Lipton JH, Vesole DH, et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007; 356: 335-47
31. Marks DI, Pagliuca A, Kibbler CC, et al. Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation. Br J Haematol 2011; 155: 318-27
32. Mennink-Kersten MA, Ruegebrink D, Wasei N, MelchersWJ, Verweij PE. In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1, 3-beta-D-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis. J Clin Microbiol 2006; 44: 1711-8
33. Mandhaniya S, Iqbal S, Sharawat SK, Xess I, Bakhshi S. Diagnosis of invasive fungal infections using real-Time PCR assay in paediatric acute leukaemia induction. Mycoses 2012; 55: 372-9
34. Nicolle MC, Benet T, Thiebaut A, et al. Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009. Haematologica 2011; 96: 1685-91
35. Greene RE, Schlamm HT, Oestmann JW, et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis 2007; 44: 373-9